Covid-19 Diagnostics Market Size to Reach US $445.4 Million Globally by the End of Frist Quarter of 2021
Pune, Maharashtra, India, February 11 2021 (Wiredrelease) Allied Analytics –:Increase in the number of covid-19 patients across the globe, immense need of rapid diagnostics, and unavailability of specific medicine or vaccine are the major factors driving the growth of the global covid-19 diagnostics market. On the other hand, lack of awareness among developing countries regarding necessary precautions and dearth of diagnostic kits and medical professionals impede the growth to some extent. However, by developing advanced diagnostic kits, the leading manufacturers are expected to be levied with multiple opportunities in the near future.
“Covid-19 Diagnostics Market by Product (PCR Kits, POC Kits and Immunoassay), Technology (Molecular and Immunoassay), and End User (Hospitals, Physician’s office & urgent care clinics and Diagnostic Labs): Global Opportunity Analysis and Industry Forecast, 2020–2022.”According to the report, the global covid-19 diagnostics industry was pegged at $7.1 million in the first quarter of 2020, and is expected to hit $445.4 million by the first quarter of 2021.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6479
– Though several trials for boosters and potential treatments are underway, there is currently no cure. And, unavailability of specific medicine or vaccine has highlighted the importance of covid-19 diagnostic tools in more than one way.
– With researchers coming together to break the testing gridlock, diagnosing checks have now started pinpointing populations who should be prioritized for immunization, which in turn, has impacted the global market significantly.
The molecular segment to retain its dominance by the first quarter of 2021 :-
Based on technology, the report segments the global covid-19 diagnostics market into molecular and immune assay. The molecular segment appeared as the major revenue holder in the first quarter of, and is expected to lead the trail by the first quarter of 2021. This is attributed to the fact that molecular assays are being highly used for the diagnosis of covid-19. Molecular assays are also considered as the gold standard for detecting new viral infections.
The diagnostic labs segment to rule the roost :-
Based on end-user, the research classifies the global covid-19 diagnostics market into hospitals, physician offices & urgent care clinics, and diagnostic labs. The diagnostic labs segment contributed to more than two-thirds of the global market share in the first quarter of 2020, and is anticipated to retain its dominance till the first quarter of 2021.
Europe to dominate in terms of revenue, North America to grow at a significant rate by the fourth quarter :-
Based on geography, Europe accounted for more than half of the global covid-19 diagnostics market in the first quarter of 2020, and is projected to maintain its leadership status by the fourth quarter of the year, owing to the presence of huge patient population in the province. The report is also analyzed across Asia-Pacific, Europe, and North America.
Key Findings Of The Study:-
– The PCR segment will dominate the global covid-19 diagnostics market till the forecast period.
– The immunoassay segment is projected to grow at a significant rate during the forecast period.
– Based on end user, the diagnosis lab segment is anticipated to dominate the market throughout the forecast period.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6479
Major Key Companies:-
Key companies working towards the development of rapid diagnostic kits for Covid-19 include F. Hoffmann-La Roche AG, Seegene Inc., Cepheid, Mylab Lifesolutions Pvt. Ltd., SureScreen Diagnostics Ltd, Cellex Inc., Genematrix, Thermo Fisher Scientific, Inc. and Robert Bosch GmbH among others.
Frequently Asked Questions By Clients:-
Question 1 :- Which are the top companies hold the market share in Covid 19 Diagnostics Market?
Answer :- Top companies such as, F. Hoffmann-La Roche AG, Seegene Inc., Cepheid, Mylab Lifesolutions Pvt. Ltd., SureScreen Diagnostics Ltd, Thermo Fisher Scientific, Genematrix, and Robert Bosch GmbH among others.
Question 2 :- Which is the most influencing segment growing in the Covid 19 Diagnostics Market report?
Answer :- Polymerase chain reaction (PCR) Kits segment is the most influencing segment owing to its increased demand for diagnosis of coronavirus patients.
Question 3 :- What are the key trends in the Covid 19 Diagnostics Market report?
Answer :- The major factor that fuels the growth of the Covid 19 Diagnostics Market includes significant increase in patient population across the globe and immense need of rapid diagnostics. Covid-19 has been declared as a pandemic by WHO. In addition, unavailability of specific medicine or a vaccine propels the covid-19 diagnostics market growth.
Question 4 :- What type of diagnostic test used to detect Covid-19 infection?
Answer :- At present, the most widely used diagnostic test for detection of Covid-19 is reverse transcriptase PCR or RT PCR. PCR is recognized as the gold standard for diagnosis of various infectious agents.
Similar Reports with COVID-19 Impact:
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises
This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at email@example.com.